BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

674 related articles for article (PubMed ID: 32515468)

  • 1. Cimifugin ameliorates imiquimod-induced psoriasis by inhibiting oxidative stress and inflammation via NF-κB/MAPK pathway.
    Liu A; Zhao W; Zhang B; Tu Y; Wang Q; Li J
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32515468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycyrrhizin ameliorates imiquimod-induced psoriasis-like skin lesions in BALB/c mice and inhibits TNF-α-induced ICAM-1 expression via NF-κB/MAPK in HaCaT cells.
    Xiong H; Xu Y; Tan G; Han Y; Tang Z; Xu W; Zeng F; Guo Q
    Cell Physiol Biochem; 2015; 35(4):1335-46. PubMed ID: 25720416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tryptanthrin ameliorates imiquimod-induced psoriasis in mice by suppressing inflammation and oxidative stress via NF-κB/MAPK/Nrf2 pathways.
    Xiong Y; Wang J; Wang S; Li H; Zhou X
    J Nat Med; 2023 Jan; 77(1):188-201. PubMed ID: 36378401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quercetin ameliorates imiquimod-induced psoriasis-like skin inflammation in mice via the NF-κB pathway.
    Chen H; Lu C; Liu H; Wang M; Zhao H; Yan Y; Han L
    Int Immunopharmacol; 2017 Jul; 48():110-117. PubMed ID: 28499194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resolvin D1 attenuates imiquimod-induced mice psoriasiform dermatitis through MAPKs and NF-κB pathways.
    Xu J; Duan X; Hu F; Poorun D; Liu X; Wang X; Zhang S; Gan L; He M; Zhu K; Ming Z; Chen H
    J Dermatol Sci; 2018 Feb; 89(2):127-135. PubMed ID: 29137840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperforin Ameliorates Imiquimod-Induced Psoriasis-Like Murine Skin Inflammation by Modulating IL-17A-Producing γδ T Cells.
    Zhang S; Zhang J; Yu J; Chen X; Zhang F; Wei W; Zhang L; Chen W; Lin N; Wu Y
    Front Immunol; 2021; 12():635076. PubMed ID: 34025642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Galangin ameliorates Imiquimod-Induced psoriasis-like skin inflammation in BALB/c mice via down regulating NF-κB and activation of Nrf2 signaling pathways.
    Sangaraju R; Alavala S; Nalban N; Jerald MK; Sistla R
    Int Immunopharmacol; 2021 Jul; 96():107754. PubMed ID: 34162135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catalpol ameliorates psoriasis-like phenotypes via SIRT1 mediated suppression of NF-κB and MAPKs signaling pathways.
    Liu A; Zhang B; Zhao W; Tu Y; Wang Q; Li J
    Bioengineered; 2021 Dec; 12(1):183-195. PubMed ID: 33323018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased βTrCP are associated with imiquimod-induced psoriasis-like skin inflammation in mice via NF-κB signaling pathway.
    Li R; Wang J; Wang X; Zhou J; Wang M; Ma H; Xiao S
    Gene; 2016 Oct; 592(1):164-171. PubMed ID: 27476970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eupatilin inhibits keratinocyte proliferation and ameliorates imiquimod-induced psoriasis-like skin lesions in mice via the p38 MAPK/NF-κB signaling pathway.
    Bai D; Cheng X; Li Q; Zhang B; Zhang Y; Lu F; Sun T; Hao J
    Immunopharmacol Immunotoxicol; 2023 Apr; 45(2):133-139. PubMed ID: 36305632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of keratinocyte necroptosis mediated by RIPK1/RIPK3/MLKL provides a protective effect against psoriatic inflammation.
    Duan X; Liu X; Liu N; Huang Y; Jin Z; Zhang S; Ming Z; Chen H
    Cell Death Dis; 2020 Feb; 11(2):134. PubMed ID: 32075957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Daphnetin inhibits proliferation and inflammatory response in human HaCaT keratinocytes and ameliorates imiquimod-induced psoriasis-like skin lesion in mice.
    Gao J; Chen F; Fang H; Mi J; Qi Q; Yang M
    Biol Res; 2020 Oct; 53(1):48. PubMed ID: 33081840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perillyl alcohol inhibits keratinocyte proliferation and attenuates imiquimod-induced psoriasis like skin-inflammation by modulating NF-κB and STAT3 signaling pathways.
    Sudha Yalamarthi S; Puppala ER; Abubakar M; Saha P; Challa VS; Np S; Usn M; Gangasani JK; Naidu VGM
    Int Immunopharmacol; 2022 Feb; 103():108436. PubMed ID: 34929480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effects of ambroxol in psoriasis like skin inflammation: Exploration of possible mechanisms.
    Sunkari S; Thatikonda S; Pooladanda V; Challa VS; Godugu C
    Int Immunopharmacol; 2019 Jun; 71():301-312. PubMed ID: 30933843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genistein suppresses psoriasis-related inflammation through a STAT3-NF-κB-dependent mechanism in keratinocytes.
    Wang A; Wei J; Lu C; Chen H; Zhong X; Lu Y; Li L; Huang H; Dai Z; Han L
    Int Immunopharmacol; 2019 Apr; 69():270-278. PubMed ID: 30743203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protectin D1 reduces imiquimod-induced psoriasiform skin inflammation.
    Park KD; Kim N; Kang J; Dhakal H; Kim JY; Jang YH; Lee WJ; Lee SJ; Kim SH
    Int Immunopharmacol; 2021 Sep; 98():107883. PubMed ID: 34153674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selenium-Rich Yeast Peptide Fraction Ameliorates Imiquimod-Induced Psoriasis-like Dermatitis in Mice by Inhibiting Inflammation via MAPK and NF-κB Signaling Pathways.
    Guo H; Li M; Liu H
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216231
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Yang BY; Cheng YG; Liu Y; Liu Y; Tan JY; Guan W; Guo S; Kuang HX
    Molecules; 2019 Jun; 24(11):. PubMed ID: 31181689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anoctamin1 Induces Hyperproliferation of HaCaT Keratinocytes and Triggers Imiquimod-Induced Psoriasis-Like Skin Injury in Mice.
    Choi MR; Kim HD; Cho S; Jeon SH; Kim DH; Wee J; Yang YD
    Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 4'-O-β-D-glucosyl-5-O-methylvisamminol ameliorates imiquimod-induced psoriasis-like dermatitis and inhibits inflammatory cytokines production by suppressing the NF-κB and MAPK signaling pathways.
    Fu J; Zeng Z; Zhang L; Wang Y; Li P
    Braz J Med Biol Res; 2020; 53(12):e10109. PubMed ID: 33146282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.